Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase

Author(s):
Simic, B.; Mocharla, P.; Crucet, M.; Osto, E.; Kratzer, A.; Stivala, S.; Kuhnast, S.; Speer, T.; Doycheva, P.; Princen, H.M.; Hoorn, J.W. van der; Jukema, J.W. (0000-0002-3246-8359); Giral, H.; Tailleux, A.; Landmesser, U.; Staels, B.; Luscher, T.F.
Published
2017
Publication type
Article / Letter to editor
CETPHyperlipidemiaEndothelial dysfunctionHDL-Cholesterol
Date issued
2017-02-28
Language
English
Is part of
Atherosclerosis (2017), Vol. 257, p. 186-194
hdl
1887/95080
doi
10.1016/j.atherosclerosis.2017.01.011